The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi

BACKGROUND The infection led by Trypanosoma cruzi persists in mammalian tissues causing an inflammatory imbalance. Carvedilol (Cv), a non-selective beta blocker drug indicated to treat heart failure and antihypertensive has shown to promote antioxidant and immunomodulatory properties which might imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Horta, Aline Luciano, Figueiredo, Vivian Paulino, Leite, Ana Luisa Junqueira, Costa, Guilherme de Paula, Menezes, Ana Paula de Jesus, Ramos, Camila de Oliveira, Pedrosa, Tamiles Caroline Fernandes, Bezerra, Frank Silva, Vieira, Paula Melo de Abreu, Talvani, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193372/
https://www.ncbi.nlm.nih.gov/pubmed/30365644
http://dx.doi.org/10.1590/0074-02760180271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193372/
https://www.ncbi.nlm.nih.gov/pubmed/30365644
http://dx.doi.org/10.1590/0074-02760180271

Ejemplares similares